S
semaglutide
Productby Novo Nordisk
Heard in 3 episodes across 3 shows since Nov 2026
Semaglutide is a glucagon-like peptide-1 (GLP-1) receptor agonist medication used to treat type 2 diabetes and, in specific formulations, chronic weight management and cardiovascular risk.
Discussed inHealth & Science67%Markets33%
Episodes
3
across 3 shows
This week
0
episodes on 0 shows
Share of the conversation
Mentions of semaglutide per 1,000 mentions of anything, 7-day rolling, across the podcasts PodLume Trends follows.
Show the data
| Day | Share (7-day) | Mentions |
|---|---|---|
| Nov 12 | 0.01‰ | 1 |
| Nov 15 | 0.02‰ | 1 |
| Nov 20 | 0.02‰ | 1 |
Email alert
Email me when semaglutide comes up on a podcast
One email a week at most, with the new episodes that mention semaglutide. Free, no account needed, unsubscribe in one click.
Episodes
3 episodes featuring semaglutide, newest first
- Nov 20, 2026
Wernicke’s often hides behind ordinary psychiatric symptomsPsychiatry & Psychotherapy PodcastNov 20, 2026 - Nov 15, 2026
Biotech investors weigh gene editing, MASH data and RAS riskBreaking BiotechNov 15, 2026 - Nov 12, 2026
GLP-1 weight loss can sacrifice muscle without a planMind Pump: Raw Fitness TruthNov 12, 2026